| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |